UK-CAB 63: Quality of life, health and wellbeing

Friday 14 July 2017

Programme (draft)

09.20-09.40 Arrival, tea and refreshments
09.40-10.00 Welcome and introductions, UK-CAB updates

Company pre-meeting

10.00-11.30 Company meeting: ViiV Healthcare
11.30-11.45 BREAK
11.45-12.30 POPPY/COBRA data on depression and quality of life – Davide De Francesco, UCL (POPPY study)
12.30-14.00 LUNCH



Invited speakers:

  1. Evidence based interventions that can improve QoL for people living with HIV – Dr Richard Harding, King’s College (tbc)
  2. HIV manifesto presentation – Silvia Petretti, Positively UK
15.30-15.45 BREAK



ViiV Healthcare feedback

King’s Fund conference feedback – Garry Brough

Community reps feedback

Reflection and feedback of the meeting member updates

16.55 AOB
17.00 Meeting close

Background reading (to follow)

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.


Published: May 9, 2017
Last edited: June 9, 2017